Andere talen Cytek Biosciences, Inc.

Aandelen

CTKB

US23285D1090

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,76 ^USD	+2,31%		-2,70%	-36,84%

20/03	Insider van Cytek Biosciences verkocht aandelen ter waarde van $269.600, volgens een recent SEC-document	MT
19/03	Cytek Biosciences benoemt William McCombe tot CFO, herbevestigt de verwachtingen voor 2024	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing	20/03
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance	19/03
Cytek® Biosciences Names William McCombe Chief Financial Officer	19/03
Cytek® Biosciences Names William McCombe Chief Financial Officer	19/03
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics	19/03
Cytek Biosciences, Inc. Announces CFO Changes	19/03
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China	08/03
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions	07/03
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions	07/03
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China	07/03
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on May 19, 2023.	01/03
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024	01/03
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook	28/02
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Cytek Biosciences to Participate in Upcoming Investor Conferences	07/02
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	07/02
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University	18/01
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries	17/01
Cytek Biosciences, Inc. Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries	17/01
Cytek Seeks Merger and Acquisitions	11/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cytek Biosciences, Inc.

Aandelen

CTKB

US23285D1090

Andere talen

Filters